Xin Hua Liu Selected Research

Xin Hua Liu Research Topics

Disease

8	Neoplasms (Cancer) 01/2022 - 12/2002
4	Arthritis (Polyarthritis) 03/2021 - 01/2019
3	Psoriasis (Pustulosis Palmaris et Plantaris) 05/2024 - 01/2022
3	Prostatic Neoplasms (Prostate Cancer) 01/2020 - 12/2002
2	Inflammation (Inflammations) 12/2022 - 12/2021
2	Colorectal Neoplasms (Colorectal Cancer) 10/2022 - 01/2022
2	Colitis 06/2022 - 01/2021
2	Rheumatoid Arthritis 01/2020 - 01/2019
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2017 - 12/2010
2	Hypoxia (Hypoxemia) 12/2010 - 12/2002
1	Colonic Neoplasms (Colon Cancer) 10/2022
1	Bronchiectasis 12/2021
1	Cystic Fibrosis (Mucoviscidosis) 12/2021
1	COVID-19 12/2021
1	Tuberculosis (Tuberculoses) 01/2021
1	Melanoma (Melanoma, Malignant) 01/2020
1	Edema (Dropsy) 09/2017
1	Cleft Palate (Palate, Cleft) 02/2015
1	Cleft Lip (Harelip) 02/2015
1	Cardiovascular Diseases (Cardiovascular Disease) 07/2012
1	Ischemic Stroke 11/2010
1	Stroke (Strokes) 11/2010
1	Infarction (Infarctions) 11/2010
1	Cardiomyopathies (Cardiomyopathy) 06/2009

Drug/Important Bio-Agent (IBA)

6	Therapeutic UsesIBA 05/2024 - 11/2010
5	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2020 - 06/2015
3	leonurineIBA 12/2010 - 06/2009
2	benzocycloheptapyridineIBA 05/2024 - 01/2022
2	InflammasomesIBA 06/2022 - 01/2021
2	Interleukin-6 (Interleukin 6)IBA 01/2022 - 01/2020
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 01/2020
2	Messenger RNA (mRNA)IBA 01/2022 - 12/2002
2	Cyclin-Dependent Kinase 8IBA 01/2022 - 01/2020
2	Phosphotransferases (Kinase)IBA 01/2022 - 01/2020
2	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 03/2021 - 01/2019
2	pyrimidineIBA 03/2021 - 01/2019
2	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 03/2021 - 01/2019
2	EnzymesIBA 11/2010 - 12/2002
1	Interleukin-10 (Interleukin 10)IBA 05/2024
1	Protein Kinases (Protein Kinase)IBA 12/2022
1	Mitogen-Activated Protein KinasesIBA 12/2022
1	paeonolIBA 12/2022
1	CateninsIBA 10/2022
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 10/2022
1	Imiquimod (Aldara)FDA LinkGeneric 01/2022
1	Interleukin-17 (Interleukin 17)IBA 01/2022
1	Serine Proteases (Serine Protease)IBA 12/2021
1	Cathepsin CIBA 12/2021
1	brensocatibIBA 12/2021
1	Cysteine Proteases (Cysteine Protease)IBA 12/2021
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2021
1	Dextrans (Dextran)FDA Link 01/2021
1	pterostilbeneIBA 01/2021
1	1,3,4-thiadiazoleIBA 01/2021
1	AmidesIBA 01/2020
1	Cyanides (Isocyanides)IBA 01/2020
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2020
1	CytokinesIBA 01/2020
1	CarrageenanIBA 09/2017
1	CCAAT-Enhancer-Binding ProteinsIBA 01/2017
1	Proteins (Proteins, Gene)FDA Link 01/2017
1	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 04/2016
1	Folic Acid (Vitamin M)FDA LinkGeneric 02/2015
1	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 07/2012
1	CystathionineIBA 07/2012
1	LyasesIBA 07/2012
1	Superoxide DismutaseIBA 11/2010
1	AntioxidantsIBA 11/2010
1	Malondialdehyde (Propanedial)IBA 11/2010
1	Neuroprotective AgentsIBA 11/2010
1	Glutathione PeroxidaseIBA 11/2010
1	Ribosome Inactivating ProteinsIBA 08/2009
1	Histone Deacetylase InhibitorsIBA 08/2009
1	Histones (Histone)IBA 08/2009
1	ProstaglandinsIBA 12/2002
1	Dinoprostone (PGE2)FDA Link 12/2002
1	Arachidonic Acid (Vitamin F)IBA 12/2002
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2002
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 12/2002
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 12/2002
1	Prostaglandins EIBA 12/2002

Therapy/Procedure

2	Therapeutics 10/2022 - 04/2016